Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Fate Therapeutics Inc.

    NASDAQ: FATE · Real-Time Price · USD
    1.03
    -0.04 (-3.74%)
    At close: May 13, 2025, 10:06 AM

    Fate Therapeutics Revenue

    Fate Therapeutics reported an annual revenue of $13.63M, reflecting a -78.55% growth. For the quarter ending December 31, 2024, Fate Therapeutics generated $1.86M in revenue.
    Revenue (ttm)
    $13.63M
    Revenue Growth
    -78.55%
    Price / Sales Ratio
    13.76
    Revenue / Employee
    $75.31K
    Employees
    181
    Market Cap
    118.04M

    Revenue Chart

    Revenue History

    Fiscal Year End Revenue % Change
    Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

    Add to Watchlist